Molecular Subtyping for Clinically Defined Breast Cancer Subgroups

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-015-0520-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mining Datasets for Molecular Subtyping in Cancer

Journal of Data Mining in Genomics & Proteomics
2016English

Breast Cancer Subtyping From Plasma Proteins

BMC Medical Genomics
Genetics
2013English

Estrogen Independent Gene Expression Defines Clinically Relevant Subgroups of Estrogen Receptor Positive Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance With Standard Clinical Molecular Markers

BMC Medical Genomics
Genetics
2012English

Molecular Subtyping of Invasive Breast Cancer and Its Relation to Common Risk Factors: A Hospital Based Study

International Journal of Recent Scientific Research
2017English

Optimizing Tissue Sampling for the Diagnosis, Subtyping, and Molecular Analysis of Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2014English

Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women

Frontiers in Oncology
Cancer ResearchOncology
2016English

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

Annals of Surgical Oncology
OncologySurgery
2016English

Radiotherapy for Initial Clinically Positive Internal Mammary Nodes in Breast Cancer

Radiation Oncology Journal
OncologyRadiologyNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy